Skip to main content

Pall Opens Proteomics Facility in Bangalore

 NEW YORK, March 21 (GenomeWeb News) - P

all has opened a Center of Excellence in Bangalore, India, the company said today. The center will include a process proteomics lab for chromatography and down-stream systems and will offer clients validation services for FDA approval.

 

“The process proteomics facility is a service to our customers, said Holly Haughney, vice president of Pall BioPharmaceuticals Marketing Asia. “In addition we will have a training facility because while there is a very well-educated technical force [in India], we’ve found that much of it is theoretical.”

 

Haughney recently relocated to the Bangalore office, along with Vinay Joban, general manager of Pall Life Sciences India.

 

Pall’s biopharm business in Asia grew by 14 percent over the last fiscal year, the company said in a statement.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.